Perhaps the 50% drop yesterday caught the attention of new buyers looking at market mover charts. Good day for the lucky few who got in at 0.1c
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%